Matches in Nanopublications for { ?s ?p "[Pathological aggregates of phosphorylated TDP-43 characterize amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP), two devastating groups of neurodegenerative disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 7 of
7
with 100 items per page.
- assertion description "[Pathological aggregates of phosphorylated TDP-43 characterize amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP), two devastating groups of neurodegenerative disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Pathological aggregates of phosphorylated TDP-43 characterize amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP), two devastating groups of neurodegenerative disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Pathological aggregates of phosphorylated TDP-43 characterize amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP), two devastating groups of neurodegenerative disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Pathological aggregates of phosphorylated TDP-43 characterize amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP), two devastating groups of neurodegenerative disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1244712.RAYPL3VOrVkbfH6G2-_WaTcJfpw6GpUG_IlgLmt5W9wm4130_assertion description "[Pathological aggregates of phosphorylated TDP-43 characterize amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP), two devastating groups of neurodegenerative disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244712.RAYPL3VOrVkbfH6G2-_WaTcJfpw6GpUG_IlgLmt5W9wm4130_provenance.
- NP1244715.RAQCnBX6g1bw2pPwZokuCclffCVdJe-ksB8RS1hFCrlbc130_assertion description "[Pathological aggregates of phosphorylated TDP-43 characterize amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP), two devastating groups of neurodegenerative disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244715.RAQCnBX6g1bw2pPwZokuCclffCVdJe-ksB8RS1hFCrlbc130_provenance.
- NP1244714.RA2B8EVp2C9BgVaIZORVR289u4bZZnwOlBiCCkegM1nGE130_assertion description "[Pathological aggregates of phosphorylated TDP-43 characterize amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD-TDP), two devastating groups of neurodegenerative disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244714.RA2B8EVp2C9BgVaIZORVR289u4bZZnwOlBiCCkegM1nGE130_provenance.